10293-06-8,
UNII-E6SHQ2AT1P,
(1R,3S,4S)-3-bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one,
E6SHQ2AT1P,
CAMPHOR, MONOBROMATED,
2-Bornanone, 3-bromo-, (1R,3S,4S)-(+)-,
Endo-3-bromo-D-camphor,
Camphor, 3-bromo-, d-,
bromocamphor,
Camphor, 3-alpha-bromo-, (+)-,
3-Bromo-d-camphor,
EINECS 233-652-1,
d-alpha-Bromocamphor,
3-Bromobornan-2-one,
BRN 3603833,
(1R,3S,4S)-(+)-3-Bromo-2-bornanone,
3-Bromocamphor, (+)-,
(1R-endo)-3-Bromo-1,7,7-trimethylbicyclo(2.2.1)heptan-2-one,
[1(r)-endo]-(+)-3-bromocamphor,
EINECS 200-950-8,
Bicyclo(2.2.1)heptan-2-one, 3-bromo-1,7,7-trimethyl-, (1R-endo)-,
MFCD00003744,
NSC 26355,
alpha-Bromocamphor,
2-Bornanone, 3-bromo- (7CI,8CI),
AC1LAFEU,
AC1OC2LL,
(+)-3-endo-bromocamphor,
Camphor, monobromated [USP],
(1R,3S)-3-bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one,
Camphor, 3-bromo- (6CI),
endo-(1R)-3-Bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one,
CHEMBL2106181,
DTXSID2022252,
SCHEMBL15823800,
(1R-endo)-(+)-3-Bromocamphor,
ZINC507383,
ANW-64036,
AKOS016003748,
SC-77391,
TC-152781,
(1R,3S,4S)-3-bromo-1,7,7-trimethyl-norbornan-2-one,
UNII-NAY429URSN component NJQADTYRAYFBJN-FWWHASMVSA-N,
(+)-3-Bromocamphor, purum, >=97.0% (sum of enantiomers, GC),
(1R,2S,4S)-2-bromo-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one,
(1S,2S,4R)-2-bromo-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one,
(+)-3-Bromocamphor,
Camphor bromide,
3-Bromocamphor,
3-Bromo-2-bornanone,
UNII-NAY429URSN,
NAY429URSN,
C10H15BrO,
TETRAHYDROXYSUCCINIC ACID,
C10-H15-Br-O,
CID512864,
( )-3-Bromocamphor, 98% - 100G 100g,
3-Bromo-1,7,7-trimethylbicyclo(2.2.1)heptan-2-one,
Bicyclo(2.2.1)heptan-2-one, 3-bromo-1,7,7-trimethyl-,
(1R-endo)-3-Bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one,
76-29-9,